Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Alvotech

Alvotech (ALVO) Stock Overview

Explore Alvotech’s financial performance, market position, analyst ratings, and future outlook.

ALVO●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$5.38
$0.04(0.75%)
U.S. Market opens in 7h 18m

Alvotech (ALVO)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-9.20
EPS (TTM)$-0.34
ROE0.77%
Fundamental Analysis

AI Price Forecasts

1 Month$5.77
3 Months$2.23
1 Year Target$0.74

ALVO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Alvotech (NASDAQ: ALVO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Alvotech's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ALVO on the NASDAQ shows an RSI of 74.86, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.74 for the NASDAQ listing.

Key metrics behind Alvotech's NASDAQ-traded stock include a P/E ratio of -9.20 and a market capitalization of 1.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ALVO on the NASDAQ.

Price Performance (NASDAQ: ALVO)

1-Day Change
0.75%
5-Day Change
11.16%
1-Month Change
41.95%
3-Month Change
71.34%
6-Month Change
41.58%
Year-to-Date (YTD) Change
4.87%
1-Year Change
-32.33%
3-Year Change
-45.49%
5-Year Change
-51.92%
All-Time (Max) Change
-51.92%

Contact Information

https://www.alvotech.com
354 422 4500
9, Rue de Bitbourg, Luxembourg, LU, 1273

Company Facts

12,790 Employees
IPO DateJun 16, 2022
CountryLU
Actively Trading

Frequently Asked Questions